These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38861414)

  • 1. 68 Ga-PSMA Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma.
    Şenses V; Kaplan İ; Kaya F; Ibiloğlu İ; Can C
    Clin Nucl Med; 2024 Sep; 49(9):e464-e467. PubMed ID: 38861414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Krenning's score on 68 Ga-DOTATATE PET-CT and miPSMA score on 68 Ga-PSMA-11 PET-CT in TENIS: a comparison with FDG PET/CT and examining the feasibility of targeted radionuclide therapy.
    Sonavane S; Salvi O; Asopa RV; Basu S
    Nucl Med Commun; 2024 Aug; 45(8):690-701. PubMed ID: 38832433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Added Value of
    Chen R; Wang Y; Zhu Y; Shi Y; Xu L; Huang G; Liu J
    J Nucl Med; 2022 Jan; 63(1):69-75. PubMed ID: 34980667
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
    Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
    Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68 Ga-FAPI Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of Bone.
    Xu W; Cai J; Meng T; Pang Y; Chen H
    Clin Nucl Med; 2023 May; 48(5):460-462. PubMed ID: 36800246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Lin R; Wang C; Chen S; Lin T; Cai H; Chen S; Yang Y; Zhang J; Xu F; Zhang J; Chen X; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):535-547. PubMed ID: 37728667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of
    Chen R; Wang Y; Shi Y; Zhu Y; Xu L; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2970-2977. PubMed ID: 33528607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
    Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
    Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
    Civan C; Isik EG; Simsek DH
    Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is 68Ga-Prostate-Specific Membrane Antigen PET/CT Superior than 18F-FDG PET/CT for Evaluation of Metastatic Osteosarcoma?
    Can C; Gündoğan C; Kömek H
    Clin Nucl Med; 2021 Apr; 46(4):e233-e235. PubMed ID: 33031232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
    Giancipoli RG; Monti S; Basturk O; Klimstra D; Keohan ML; Schillaci O; Corrias G; Sawan P; Mannelli L
    Medicine (Baltimore); 2018 Oct; 97(42):e12795. PubMed ID: 30334971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of
    Aggarwal P; Singh H; Das CK; Mavuduru RS; Kakkar N; Lal A; Gorsi U; Kumar R; Mittal BR
    Eur J Radiol; 2024 Jan; 170():111218. PubMed ID: 38007857
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hirmas N; Leyh C; Sraieb M; Barbato F; Schaarschmidt BM; Umutlu L; Nader M; Wedemeyer H; Ferdinandus J; Rischpler C; Herrmann K; Costa PF; Lange CM; Weber M; Fendler WP
    J Nucl Med; 2021 Sep; 62(9):1235-1241. PubMed ID: 33509970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of quantitative whole body PET parameters on [
    Ayati N; McIntosh L; Buteau J; Alipour R; Pudis M; Daw N; Jackson P; Hofman MS
    Cancer Imaging; 2024 May; 24(1):57. PubMed ID: 38711135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental 68 Ga-PSMA Uptake in the Benign Enchondroma-A Rare Finding on 68 Ga-PSMA PET/CT.
    Singh P; Kandula KK; Patel RK; Parida GK; Agrawal K
    Clin Nucl Med; 2024 Oct; 49(10):e525-e527. PubMed ID: 38934470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of
    Can C; Gündoğan C; Yildirim OA; Poyraz K; Güzel Y; Kömek H
    Hell J Nucl Med; 2021; 24(1):25-35. PubMed ID: 33866336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18 F-FDG PET/CT Imaging of Prostatic Epithelioid Hemangioendothelioma.
    Deng Y; Deng Y; He L; Zhang W; Lei X
    Clin Nucl Med; 2024 Feb; 49(2):191-192. PubMed ID: 38049968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between whole body volumetric parameters of
    Yildirim ÖA; Gündoğan C; Can C; Poyraz K; Erdur E; Kömek H
    Ann Nucl Med; 2021 May; 35(5):540-548. PubMed ID: 33586097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.